Janet SkinnerTop StoriesMRIPI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRIPI-RADS v2.1 was developed by the ACR and the European Society of Urogenital Radiology (ESUR) and released in 2019.CTBreast CT gains clinical momentum in EuropeCTBelgian study shows AI's promise in coronary ischemiaArtificial IntelligenceAI on the Aegean: EuSoMII congress comes to CreteDigital X-RayAI fracture detection tools tested head-to-head